ORCL
63
-4
CNX
73
-3
UPS
48
2
WYNN
36
-5
HAL
48
-3
FTI
71
-7
RIG
43
-7
ADP
65
-3
MTCH
20
-8
YUM
43
-6
GOOG
57
-6
SRE
63
2
SCHW
62
-2
HSIC
45
5
FOX
51
-6
CFG
74
2
STT
64
2
OI
42
-3
USB
50
-3
TGT
45
-4
ORCL
63
-4
CNX
73
-3
UPS
48
2
WYNN
36
-5
HAL
48
-3
FTI
71
-7
RIG
43
-7
ADP
65
-3
MTCH
20
-8
YUM
43
-6
GOOG
57
-6
SRE
63
2
SCHW
62
-2
HSIC
45
5
FOX
51
-6
CFG
74
2
STT
64
2
OI
42
-3
USB
50
-3
TGT
45
-4
Financhill
Back

Avantis All International Mkts Eq ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
25

AVNM
Avantis All International Mkts Eq ETF

Last Price:
56.05
Seasonality Move:
7.18%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
25
Avantis All International Mkts Eq ETF (AVNM) is a Sell

Is Avantis All International Mkts Eq ETF a Buy, Sell or Hold?

  • The current Avantis All International Mkts Eq ETF [AVNM] share price is $56.05. The Score for AVNM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • AVNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AVNM Stock Price Chart

What is Avantis All International Mkts Eq ETF's stock price today?

  • The Avantis All International Mkts Eq ETF share price today is $56.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVNM is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AVNM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 34.92 Sell
Chaikin Money Flow: 982 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.89 - 58.71) Sell
Bollinger Bands (100): (56.14 - 58.96) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AVNM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.98 Sell
20-day SMA: 57.52 Sell
50-day SMA: 58.3 Sell
200-day SMA: 56.69 Sell
8-day EMA: 56.73 Sell
20-day EMA: 57.42 Sell
50-day EMA: 57.84 Sell
200-day EMA: 56.36 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Avantis All International Mkts Eq ETF Earnings Growth & AVNM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Avantis All International Mkts Eq ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):